AVXL
Closed
Anavex Life Sciences Corp
9.33
+0.11 (+1.19%)
Last Update: 01 Jul 2025 23:03:00
Yesterday: 9.22
Day's Range: 9.075 - 9.61
Send
sign up or login to leave a comment!
When Written:
8.57
Anavex Life Sciences Corp is a biopharmaceutical company focused on the development of novel therapeutics for the treatment of central nervous system (CNS) diseases. The company's lead drug candidate is ANAVEX 2-73, which is being developed for the treatment of Alzheimer's disease, Parkinson's disease, and other CNS disorders.
ANAVEX 2-73 is a small molecule drug that targets sigma-1 receptors and muscarinic receptors, which are involved in the regulation of key cellular pathways in the brain. The drug has shown promising results in preclinical studies, including improved cognitive function and reduced neuroinflammation.
In addition to ANAVEX 2-73, Anavex Life Sciences Corp is also developing other drug candidates for the treatment of CNS disorders, including ANAVEX 3-71 for the treatment of epilepsy and Rett syndrome, and ANAVEX 1-41 for the treatment of depression and anxiety.
The company was founded in 2006 and is headquartered in New York City. Anavex Life Sciences Corp is listed on the NASDAQ stock exchange under the ticker symbol "AVXL".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
ANAVEX 2-73 is a small molecule drug that targets sigma-1 receptors and muscarinic receptors, which are involved in the regulation of key cellular pathways in the brain. The drug has shown promising results in preclinical studies, including improved cognitive function and reduced neuroinflammation.
In addition to ANAVEX 2-73, Anavex Life Sciences Corp is also developing other drug candidates for the treatment of CNS disorders, including ANAVEX 3-71 for the treatment of epilepsy and Rett syndrome, and ANAVEX 1-41 for the treatment of depression and anxiety.
The company was founded in 2006 and is headquartered in New York City. Anavex Life Sciences Corp is listed on the NASDAQ stock exchange under the ticker symbol "AVXL".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!